New Route of Prostate Cancer Growth Discovered by Cancer Research UK Scientists
A recent prostate cancer research findings published in the “Molecular Endocrinology” has revealed a new route for the development of male androgen hormones that influences the growth of prostate cancer.
This new study is significant in that it leads to the possibility of treating this condition with drugs that already exist. Details of this research reveal the interactions of proteins such as the p23 and HSP90 with androgen receptor (AR). The following online extract gives you further details on this study:
Cancer Research UK scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease.
Prostate cancers are often treated with hormone therapies that target the androgen receptor (AR) – a large protein that switches on signals telling the cell to divide, and which can become overactive in prostate cancer cells. AR relies on interactions with several other proteins, such as HSP90 and p23, which help fold it into its active form.
Previously it was thought that p23 and HSP90 work together to activate AR, but this latest research – funded by Cancer Research UK and the Association for International Cancer Research – shows that p23 also increases activity of the AR independently.
Crucially this means that drugs to block p23 could be effective at treating prostate cancers that have become resistant to HSP90 inhibitors – which are currently being trialled in breast and prostate cancers.
The findings are published in Molecular Endocrinology.
Study leader, Dr Charlotte Bevan, from the Department of Surgery and Cancer at Imperial College London, said: “Cell signals from the androgen receptor (AR) drive many prostate cancers and our team is part of an ongoing international effort to find new drug targets that can potentially disable this key protein.
“Previously it was thought that HSP90 and p23 went hand in hand, so we were surprised to find that p23 was also able to boost the activity of the androgen receptor even when we used a modified form that was unable to bind HSP90.
“Excitingly, drugs that block p23 such as Celastrol, which is derived from a plant used in Chinese medicine, have shown early promise in treating several diseases, such as arthritis and asthma, meaning this research is already a step closer to the clinic. The next stage will be to test the effects of such drugs on prostate cancer cells in the lab.”
The researchers used antibodies specifically designed to target p23 to show that levels of the protein are higher in the nucleus of prostate cancer cells compared to normal cells. They also used a modified form of p23, unable to bind HSP90, to show that p23 can act independently of HSP90 and does not necessarily need the protein to interact with the AR.
Dr Julie Sharp, senior science information manager at Cancer Research UK, said: “These results provide an alternative route by which scientists could potentially target prostate cancer by halting AR activity. What’s more, p23 has a much more defined role in the cell than HSP90, meaning that drugs that target it could potentially have fewer side effects for patients than HSP90 inhibitors. We hope these findings will lead to better treatment options for men with prostate cancer.” Source.
This new study is sure to help in finding better treatments to millions out there which are suffering from the diseases. The National Cancer Institute (NCI) in the United States reveals that about 28000 men are likely to be diagnosed with this condition this year.
If the details from the above research is anything to go by then it is likely that better hope are in the offing for the large number of men suffering from the disease. So there is hope to curb this disease.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- New Molecule That Stimulate Growth of Prostate Cancer Discovered
- American Cancer Society Prostate Cancer Research and Academic Study and Research
- Scientists Identify a Protein that May Cause Aggressive Prostate Cancer
- Molecular Subtype of Prostate Cancer Discovered
- Scientists Discover New Type of Prostate Cancer in Men
- Prostate Cancer Progression – The Rate Of Growth
- Prostate Cancer Spreading – Growth Progression and Metastasis
- Donations for Prostate Cancer and Fundraising for Research
- Scientists May Use Human DNA to Treat Advanced Prostate Cancer